CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,558 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Commercial Officer gave up 13,257 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 4 Option exercise Director acquired 37,500 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- RW Other RW
- S-3 Offering Registration Statement
- 4 Shares withheld for taxes Chief Commercial Officer gave up 5,965 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,187 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,185 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 35,826 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 7,777 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
Page 23 of 41 · 802 filings